2622 Results

People

  1. Reuter
    Reuter
  2. Fong
    Fong
  3. Motzer
    Motzer
  4. Brennan
    Brennan
  5. Akin
    Akin
  6. Eastham
    Eastham
  7. Fine
    Fine
  8. Rusch
    Rusch
  9. Abrey
    Abrey
  10. Gonen
    Gonen

Groups

  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)
  7. Department of Pathology and Laboratory Medicine (272)
  8. Molecular Pharmacology and Chemistry Program Faculty (271)
  9. Population Sciences Research Program (269)
  10. Radiology, Department of (237)
  1. "2007"
Formats
  1. Journal Article (1654)
  2. Meeting Abstract (774)
  3. Book Section (162)
  4. Conference Paper (22)
  5. Book Whole (10)
Groups
  1. Department of Medicine (744)
  2. Surgery (660)
  3. Sloan Kettering Institute Faculty (490)
  4. GSK Faculty (474)
  5. Solid Tumor Oncology Division (435)
  6. Survivorship Research (381)

More Groups

People
  1. Peter Scardino (58)
  2. Victor Reuter (53)
  3. Yuman Fong (50)
  4. Oguz Akin (48)
  5. Robert Motzer (48)
  6. Murray Brennan (46)

More People

Years
  1. 2007 (2622)
Publications
  1. Journal of Clinical Oncology (228)
  2. Blood (75)
  3. Annals of Surgical Oncology (71)
  4. International Journal of Radiation Oncology, Biology, Physics (61)
  5. Modern Pathology (56)
  6. Laboratory Investigation (53)

More Publications

Publishers
  1. Elsevier Inc. (279)
  2. American Society of Clinical Oncology (229)
  3. Springer (187)
  4. Nature Publishing Group (152)
  5. American Association for Cancer Research (131)
  6. Elsevier Science, Inc. (126)

More Publishers

Results (2622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depression and anxiety
    Book Section

    Miller, K.; Massie, M. J.
    In Berger, A. M; Shuster, J. L. Jr; Von Roenn, J. H. (Eds.) Principles and Practice of Palliative Care and Supportive Oncology. 3rd ed (2007)

    Fulltext@MSK | Save
  • Physiatric approaches to pain management
    Book Section

    Cheville, A.; Shaiova, L.
    In Berger, A. M.; Shuster, J. L. Jr; Von Roenn, J. H. (Eds.) Principles and Practice of Palliative Care and Supportive Oncology. 3rd ed (2007)

    Fulltext@MSK | Save
  • Difficult pain syndromes: Bone pain, visceral pain, neuropathic pain
    Book Section

    Pappagallo, M.; Shaiova, L.; Perlov, E.; Knotkova, H.
    In Berger, A. M.; Shuster, J. L. Jr; Von Roenn, J. H. (Eds.) Principles and Practice of Palliative Care and Supportive Oncology. 3rd ed (2007)

    Fulltext@MSK | Save
  • Electrophoretic NMR of protein mixtures and its proteomic applications
    Book Section

    He, Q.; Thakur, S. B.; Spater, J.
    In Sem, D. S. (Eds.) Spectral Techniques in Proteomics (2007)

    Fulltext@MSK | Save
  • A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal, and peritoneal carcinoma
    Meeting Abstract

    Zivanovic, O.; Chi, D. S.; Eisenhauer, E. L.; Sonoda, Y.; Levine, D. A.; Brown, C. L.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Clinical outcome of glioblastoma multiforme patients with long-term survival
    Meeting Abstract

    Yoon, H.; Hottinger, A. F.; DeAngelis, L. M.; Lassman, A. B.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term cardiac outcomes following low-dose anthracycline exposure
    Meeting Abstract

    Wright, J. A.; Reimold, S.; Turoff, A.; Brooks, S.; Huet, B.; Eshelman, D.; Winick, N.; Oeffinger, K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Final results from phase II study of volociximab, an α5ß1 anti-integrin antibody, in refractory or relapsed metastatic clear cell renal cell carcinoma (mCCRCC)
    Meeting Abstract

    Yazji, S.; Bukowski, R.; Kondagunta, V.; Figlin, R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
    Meeting Abstract

    Zhang, W.; Yang, D.; Capanu, M.; Hollywood, E.; Lue-Yat, M.; Borucka, E.; Azuma, M.; Gordon, M.; Saltz, L.; Lenz, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Vandetanib in metastatic hereditary medullary thyroid cancer: Follow-up results of an open-label phase II trial
    Meeting Abstract

    Wells, S. A. Jr; Gosnell, J. E.; Gagel, R. F.; Moley, J. F.; Pfister, D. G.; Sosa, J. A.; Skinner, M.; Krebs, A.; Hou, J.; Schlumberger, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save